In vivo and in vitro characterisation of a nonpeptide vasopressin V 1A and V 2 receptor antagonist (YM087) in the rat

By Risvanis J.   Naitoh M.   Johnston C.I.   Burrell L.M.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite

Ameliorative effect of vasopressin-(4-9) through vasopressin V 1A receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze

By Mishima K.   Tsukikawa H.   Inada K.   Fujii M.   Iwasaki K.   Matsumoto Y.   Abe K.   Egawa T.   Fujiwara M.  

European Journal of Pharmacology, Vol. 427, Iss. 1, 2001-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Renin-angiotensin system in stretch-induced hypertrophy of cultured neonatal rat heart cells

By Miyata S.   Haneda T.   Osaki J.   Kikuchi K.  

European Journal of Pharmacology, Vol. 307, Iss. 1, 1996-06 ,pp. : 81-88

Elsevier

Access to resources Recommend Favorite

Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells

By Oi S.   Haneda T.   Osaki J.   Kashiwagi Y.   Nakamura Y.   Kawabe J.   Kikuchi K.  

European Journal of Pharmacology, Vol. 376, Iss. 1, 1999-07 ,pp. : 139-148

Elsevier

Access to resources Recommend Favorite

Conditions that Lithium Inhibits or Potentiates Vasopressin V 1 -Receptor-Mediated Platelet Aggregation and [Ca ++ ] i Mobilization

By Dehpour A.R.   Kiani K.   Ghafourifar P.   Mousavizadeh K.  

General Pharmacology, Vol. 26, Iss. 8, 1995-12 ,pp. : 1659-1667

Elsevier

Access to resources Recommend Favorite